Federated Hermes, Inc. Ideaya Biosciences, Inc. Transaction History

Federated Hermes, Inc.

$52.5 Billion
Q3 2025

A detailed history of Federated Hermes, Inc. transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 4,625,850 shares of IDYA stock, worth $149 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

4,625,850

Previous 4,627,266 0.03%

Holding current value

$149 Million

Previous $97.3 Million 29.41%

% of portfolio

0.24%

Previous 0.19%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 03, 2025	SELL	$21.12 - $27.21 $29,905 - $38,529	-1,416 Reduced 0.03%	4,625,850 $126 Million
Q2 2025 Aug 13, 2025	SELL	$14.5 - $22.63 $2.04 Million - $3.18 Million	-140,660 Reduced 2.95%	4,627,266 $97.3 Million
Q1 2025 May 08, 2025	SELL	$16.38 - $26.0 $4.84 Million - $7.69 Million	-295,600 Reduced 5.84%	4,767,926 $78.1 Million
Q4 2024 Feb 13, 2025	SELL	$24.79 - $31.98 $3.59 Million - $4.63 Million	-144,774 Reduced 2.78%	5,063,526 $130 Million
Q3 2024 Nov 13, 2024	BUY	$30.37 - $43.05 $10.7 Million - $15.2 Million	352,510 Added 7.26%	5,208,300 $165 Million
Q2 2024 Aug 08, 2024	SELL	$34.37 - $43.46 $9,898 - $12,516	-288 Reduced 0.01%	4,855,790 $170 Million
Q1 2024 May 14, 2024	BUY	$34.2 - $47.13 $33.3 Million - $45.8 Million	972,303 Added 25.03%	4,856,078 $213 Million
Q4 2023 Jan 31, 2024	BUY	$24.59 - $35.83 $12.3 Million - $17.9 Million	500,046 Added 14.78%	3,883,775 $138 Million
Q3 2023 Nov 13, 2023	SELL	$21.07 - $29.77 $125,766 - $177,697	-5,969 Reduced 0.18%	3,383,729 $91.3 Million
Q2 2023 Aug 14, 2023	BUY	$13.33 - $25.53 $7 Million - $13.4 Million	525,091 Added 18.33%	3,389,698 $79.7 Million
Q1 2023 May 08, 2023	BUY	$13.49 - $18.72 $1,443 - $2,003	107 Added 0.0%	2,864,607 $39.3 Million
Q4 2022 Feb 13, 2023	BUY	$14.47 - $18.17 $34,858 - $43,771	2,409 Added 0.08%	2,864,500 $52 Million
Q3 2022 Nov 14, 2022	BUY	$9.24 - $15.79 $6.47 Million - $11.1 Million	700,000 Added 32.38%	2,862,091 $42.7 Million
Q2 2022 Aug 15, 2022	SELL	$8.28 - $13.88 $721,096 - $1.21 Million	-87,089 Reduced 3.87%	2,162,091 $29.8 Million
Q1 2022 May 13, 2022	SELL	$11.18 - $24.02 $459,520 - $987,270	-41,102 Reduced 1.79%	2,249,180 $25.2 Million
Q4 2021 Feb 14, 2022	SELL	$20.95 - $26.88 $312,029 - $400,350	-14,894 Reduced 0.65%	2,290,282 $54.1 Million
Q3 2021 Nov 15, 2021	BUY	$17.26 - $27.08 $11.5 Million - $18.1 Million	668,237 Added 40.82%	2,305,176 $58.8 Million
Q2 2021 Aug 16, 2021	BUY	$17.76 - $24.83 $2.32 Million - $3.25 Million	130,727 Added 8.68%	1,636,939 $34.4 Million
Q1 2021 May 13, 2021	BUY	$13.48 - $23.77 $5.5 Million - $9.69 Million	407,864 Added 37.13%	1,506,212 $35.4 Million
Q4 2020 Feb 12, 2021	BUY	$12.17 - $17.52 $13.4 Million - $19.2 Million	1,097,266 Added 101410.91%	1,098,348 $15.4 Million
Q3 2020 Nov 12, 2020	BUY	$11.22 - $14.46 $12,140 - $15,645	1,082 New	1,082 $14,000

Others Institutions Holding IDYA

# of Institutions

242

Shares Held

82.2M

Call Options Held

509K

Put Options Held

103K

View Full List

About IDEAYA Biosciences, Inc.

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.54B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

More about IDYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Ideaya Biosciences, Inc. Transaction History